Effect of low-dose aspirin on the markers of oxidative stress

Cardiovascular Drugs and Therapy

Volumn 13, Issue 6, 1999, Pages 485-490

  Ristimäe, Tiina ^a,b   Zilmer, Mihkel ^b   Zilmer, Kersti ^b   Kairane, Czeslawa ^b   Kullisaar, Tiiu ^b   Teesalu, Rein ^a  

^a Department of Cardiology ^*  (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

Author keywords

Healthy middle aged subjects; Low dose aspirin; Oxidative stress

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; MARKER;

ADULT; ARTICLE; ATHEROGENESIS; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENTERIC COATED TABLET; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; MALE; NORMAL HUMAN; OXIDATIVE STRESS; PRIMARY PREVENTION; PRIORITY JOURNAL;

ADULT; ANTIOXIDANTS; ASPIRIN; BIOLOGICAL MARKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; LIPIDS; MALE; MIDDLE AGED; OXIDATIVE STRESS; TABLETS, ENTERIC-COATED;

EID: 0033373519     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007867402152     Document Type: Article

References (28)

1. 1. Antioxidants in disease mechanisms and therapy. In: Sies H (ed). Advances in Pharmacology, vol. 38, New York: Academic Press, 1997.
2. 2. Pincemail J, Defraigne JO, Limet R. Oxidative stress in clinical situations - fact of fiction? Eur J Anesthesiol 1996;13:219-252.
3. 3. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Rad Biol Med 1996;20:707-727.
4. 4. Mak IT, Weglicki WB. Antioxidant activity of calcium channel blocking drugs. Methods Enzymol 1994;234:620-630.
5. 5. Diaz MN, Frei B, Vita JA, Keany JF. Mechanisms of disease: antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337(6):408-416.
6. 6. Free radical and antioxidant protocol. In: Amstrong D (ed). Methods in Molecular Biology, vol. 108. Totowa, NJ: Humana Press, 1998.
7. 7. Starkopf J, Zilmer K, Vihalemm T, Kullisaar T, Zilmer M, Samarütel J. Time course study of oxidative stress during open heart surgery. Scandinavian J Thoracic and Cardiovasc Surgery 1995;29:181-186.
8. 8. Recknagel RO, Glende EA. Spectrophotometric detection of lipid conjugated dienes. Methods Enzymol 1984;105:331-337.
9. 9. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
10. 10. Ellman G. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
11. 11. Beutler E, Duron O, Kelly B. An improved method for the determination of blood glutathione. J Lab Clin Med 1963;61;822-826
12. 12. Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 1991;196:143-152.
13. 13. Zhang A, Vertommen J, Van Gaal L, De Leeuw I. A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipoprotein to copper-catalyzed oxidation. Clinica Chimica Acta 1994;227:159-173.
14. 14. Esterbauer H, Wäg G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull 1993;49:566-576.
15. 15. Kehrer JP. Free radicals as mediators of tissue injury and disease. Crit Rev in Toxicol 1993;23:21-48.
16. 16. Darley-Usmar V, Halliwell B. Blood radicals. Reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res 1996:13:649-663.
17. 17. Girona J, La Ville AE, Solà R, Plana N, Masana L. Simvastatin decreases aldehyde production derived from lipoprotein oxidation. Am J Cardiol 1999;83:846-851.
18. 18. Charma M, Chandra N, Agrawal R, Kumar A, Ghatak A, Pandey VC. The free radical system in ischemic heart disease. Int J Cardiol 1994;43:121-125.
19. 19. Niskanen LK, Salonen JT, Nyysönen K, Uusitupa MIJ. Plasma lipid peroxidation and hyperglycemia: A connection through hyperinsulinaemia? Diab Med 1995;12:802-808.
20. 20. Maggi E, Marchesi E, Covini D, Negro C, Perani G, Bellomo G. Low-density oxidation in essential hypertension. J Hypertens 1993;11:1103-1111.
21. 21. Clemens MR, Ruess M, Bursa Z, Waller HD. The relationship between lipid composition of red blood cells and their susceptibility to lipid peroxidation. Free Rad Res Comms 1987;3:1-5.
22. 22. Parassi T, Giusti AM, Raimondi M, Ravagnan G, Sapora O, Gratoon E. Cholesterol protects the phospholipid bilayer from oxidative damage. Free Rad Biol Med 1995;19:511-516.
23. 23. Thomas MJ, Thornborg T., Manning J, Hooper K, Rudel LL. Fatty acid composition of low-density lipoprotein influences its susceptibility to autooxidation. Biochemistry 1994;33: 1828-1834.
24. 24. Keaney JF Jr, Xu A, Cunningham D, Jackson T, Frei B, Vita JA. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest 1995:95:2520-2529.
25. 25. Shaish A, Daugherty A, O'Sullivan F, Schonfeld G, Heinecke JW. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest 1995:96:2075-2082.
26. 26. Davidge ST, Hubel CA, McLaughlin MK. Lipid peroxidation increases arterial cyclooxygenase activity during pregnancy. Am J Obstet Gynecol 1994;170:215-222.
27. 27. Reilly IAG, Fitzgerald GA. Aspirin in cardiovascular disease. Drugs 1988:35:154-176.
28. 28. de Gaetano G, Cerletti C, Bertele V. Pharmacology of anti-platelet drugs and clinical trials on thrombosis prevention: A difficult link. Lancet 1982;2:974-977.